Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 27, 2023 (3 years ago)

Lisinopril Tablets USP 20 mg (Buspirone Hydrochloride)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Lisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count blister card (NDC 0615-8255-39), Rx only, Mfd By Lupin, PKG by Vangard Glasgow, KY 42141.

Affected NDCs 0615-7718-05 0615-8255-39

Compare with the code on your package — it is the most precise check available.

Drug: Lisinopril Category: Blood Pressure Medication

Product details

From the FDA NDC directory, for the product codes this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Buspirone Hydrochloride
NDC 00615-7718
10 mg/1 Tablet
Oral
NCS HealthCare of KY, LLC dba Vangard Labs Rx
Lisinopril
NDC 00615-8255
20 mg/1 Tablet
Oral
NCS HealthCare of KY, LLC dba Vangard Labs Rx
Recalling firm
NCS Healthcare of Kentucky Inc
NDC code
0615-7718-05
Origin
KY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0114-2024 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Lisinopril recalls

See all
Class II · Moderate risk

Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg

Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.

Ongoing Labeling / mix-up Lupin Pharmaceuticals Inc. NDC 68180-519-01 D-0532-2025
Class II · Moderate risk

Lisinopril Tablets

Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.

Terminated Particulate / foreign matter Evaric Pharmaceuticals Inc. NDC 68645-610-90 D-0061-2025

Other recalls by NCS Healthcare of Kentucky Inc

All 2023 recalls
Class II · Moderate risk

Glycopyrrolate Tabs

Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.

Terminated Impurity / degradation NCS Healthcare of Kentucky Inc NDC 0615-8170-39 D-0850-2020